Repo Dosen ULM

TUR - 2023 - Survival of Lung Adenocarcinoma Patients with Tyrosine Kinase Inhibitor Therapy Based on EGFR Mutation Status in Tumor and Plasma Samples

TUR - 2023 - Survival of Lung Adenocarcinoma Patients with Tyrosine Kinase Inhibitor Therapy Based on EGFR Mutation Status in Tumor and Plasma Samples

Oktaviyanti, Ika Kustiyah
URI: https://repo-dosen.ulm.ac.id//handle/123456789/35062
Date: 2023

Show full item record

Files in this item

Icon
Name: TUR - 2023 - Survival ...
Size: 1.507Mb
Format: PDF
View/Open

This item appears in the following Collection(s)

Search DSpace


Browse

My Account